✦ LIBER ✦

Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial

✍ Scribed by D. Schmidt; R. Jacob; P. Loiseau; E. Deisenhammer; D. Klinger; A. Despland; M. Egli; G. Bauer; E. Stenzel; V. Blankenhorn

Book ID: 103932319
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 761 KB
Volume: 15
Category: Article
ISSN: 0920-1211
DOI: 10.1016/0920-1211(93)90011-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pregabalin add-on therapy using a flexib

Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: A double-blind, randomized, placebo-controlled, multicenter trial

✍ Byung In Lee; Sangdoe Yi; Seung Bong Hong; Myeong-Kyu Kim; Sang Ahm Lee; Sang Ku 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 245 KB

A double-blind, placebo-controlled trial

A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

✍ Reetta Kälviäinen; Martin J Brodie; John Duncan; David Chadwick; David Edwards; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Multicenter Double-Blind, Randomized, Pl

Multicenter Double-Blind, Randomized, Placebo-Controlled Trial of Levetiracetam as Add-On Therapy in Patients with Refractory Partial Seizures

✍ Simon D. Shorvon; Armand Löwenthal; Dieter Janz; Edith Bielen; Pierre Loiseau; f 📂 Article 📅 2000 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 672 KB

Double-blind crossover trial of lamotrig

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy

✍ C.D. Binnie; R.M.C. Debets; M. Engelsman; J.W.A. Meijer; H. Meinardi; J. Overweg 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 502 KB

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy

✍ J.W.A.S. Sander; P.N. Patsalos; J.R. Oxley; M.J. Hamilton; W.C. Yuen 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 616 KB

A randomised double-blind placebo-contro

A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures

✍ P. Loiseau; A.W.C. Yuen; B. Duché; T. Ménager; M.C. Arné-Bès 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 874 KB

Efficacy and safety of lamotrigine (LTG) as add-on therapy was assessed in a randomised double-blind placebo-controlled trial of this drug in 23 adult patients with refractory partial seizures. Fifteen patients showed an improvement on LTG treatment, with a greater than 50% decrease in total seizure